Escalon Medical Corp. (ESMC) Gross margin 2017–2026
Escalon Medical Corp. (ESMC) gross margin by fiscal year — reported gross profit divided by reported revenue.
43.7%FY2026 · since FY2017: 45.9% → 43.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 43.7% | -2.0 pp |
| FY2025 | 45.7% | +2.8 pp |
| FY2024 | 43.0% | -2.1 pp |
| FY2023 | 45.0% | +2.0 pp |
| FY2022 | 43.0% | +0.8 pp |
| FY2021 | 42.3% | -2.4 pp |
| FY2020 | 44.7% | -3.4 pp |
| FY2019 | 48.1% | +3.3 pp |
| FY2018 | 44.8% | -1.1 pp |
| FY2017 | 45.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ESMC financial trends
ESMC RevenueESMC Net incomeESMC Net marginESMC Gross profitESMC Operating incomeESMC Operating marginESMC Operating cash flowESMC Free cash flowESMC Capital expendituresESMC Return on equityESMC Stock buybacksESMC Dividends paidESMC Total assetsESMC Total liabilitiesESMC Shareholders’ equityESMC overview →